SRRK Scholar Rock Holding Corp

Scholar Rock Holding Corp is a biopharmaceutical company. It is engaged in the discovery and development of innovative medicines for the treatment of serious diseases including neuromuscular disorders, cancer, fibrosis, and anemia.

$6.45  -0.97 (-13.07%)
As of 09/23/2022 15:59:56 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  05/24/2018
Outstanding shares:  51,640,650
Average volume:  278,870
Market cap:   $333,082,193
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BFZQ0L8
Valuation   (See tab for details)
PE ratio:   -3.42
PB ratio:   1.53
PS ratio:   7.04
Return on equity:   -65.42%
Net income %:   -236.95%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy